Harmaline, a potent inhibitor of sodium-dependent transport.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites; D001692:Biological Transport / Q000187:drug effects; D002250:Carbon Radioisotopes; D003864:Depression, Chemical; D004285:Dogs; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007413:Intestinal Mucosa / Q000378:metabolism; D007672:Kidney Cortex / Q000378:metabolism; D008757:Methylglucosides / Q000378:metabolism; D010649:Phenylalanine / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism / Q000494:pharmacology*; D013997:Time Factors
D000470:Alkaloids; D002250:Carbon Radioisotopes; D007211:Indoles; D008757:Methylglucosides; D011725:Pyridines; D010649:Phenylalanine; D012964:Sodium